SCHEMBL29875282

SCHEMBL29875282

Cc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc2C)C3)cn1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNK2 Q07912 19/20 1.00
MAP4K2 Q12851 19/20 1.00
ABL1 P00519 3/20 1.00
BMX P51813 3/20 1.00
BCR P11274 1/20 1.00
RIPK1 Q13546 1/20 1.00
RIPK3 Q9Y572 1/20 1.00
MAPK3 P27361 1/20 0.81
LCK P06239 1/20 0.78
FES P07332 1/20 0.78
RET P07949 1/20 0.78
PDGFRB P09619 1/20 0.78
KIT P10721 1/20 0.78
FGFR1 P11362 1/20 0.78
SRC P12931 1/20 0.78
PDGFRA P16234 1/20 0.78
FLT1 P17948 1/20 0.78
FGFR3 P22607 1/20 0.78
EPHA3 P29320 1/20 0.78
KDR P35968 1/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3135042 1.00 TNK2 (1.00) TNK2MAP4K2ABL1BMXBCR
SCHEMBL29404264 1.00 TNK2 (1.00) TNK2MAP4K2ABL1BMXBCR
SCHEMBL3132435 0.96 TNK2 (0.92) TNK2MAP4K2ABL1BMXBCR
SCHEMBL3139165 0.94 TNK2 (0.89) TNK2MAP4K2ABL1BMXBCR
SCHEMBL3132500 0.94 TNK2 (0.88) TNK2MAP4K2ABL1BMXBCR
SCHEMBL3136175 0.93 TNK2 (0.90) TNK2MAP4K2ABL1BMXBCR
SCHEMBL3137360 0.93 TNK2 (0.88) TNK2MAP4K2ABL1BMXBCR
SCHEMBL13521779 0.93 TNK2 (0.93) TNK2MAP4K2ABL1BMXBCR
SCHEMBL3134169 0.93 TNK2 (1.00) TNK2MAP4K2ABL1BMXBCR
SCHEMBL3132265 0.92 TNK2 (0.84) TNK2MAP4K2ABL1BMXBCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110151767-B Application of GNF-7 in preparation of medicine for treating influenza virus infection 武汉威立得生物医药有限公司 2022-10-18 CN disclosed